High Dose Samarium-153 With Peripheral Blood Stem Cell Support in High Risk Osteogenic Sarcoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Filgrastim; Filgrastim; Ifosfamide; Samarium 153 lexidronam
- Indications Osteosarcoma
- Focus Therapeutic Use
- 10 Mar 2020 Biomarkers information updated
- 11 Jun 2012 Actual patient number is 11 according to ClinicalTrials.gov.
- 11 Jun 2012 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.